Redeye: Moberg Pharma - Realizing value

By reshaping itself through the sale of the OTC business and its new partnership with Bayer, Moberg Pharma has confirmed management's strong commitment to creating and realizing shareholder value. We raise our Management rating and feel increased conviction in the company as a late-stage clinical development play.

Read more and download the Research Update: http://bit.ly/2TEjm1o

Start following companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. https://www.redeye.se/about/